Long-Term Cardiovascular or Neurological Manifestations of Post-Acute COVID-19
International Journal of Current Pharmaceutical Review and Research · 31.03.2026 · 18 (03)
DOI: 10.25258/ijcpr.18.3.232 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 31.03.2026. Verfasst von Sanjeev Johri und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Aim
Post-acute COVID-19, also termed post-COVID-19 condition or long COVID, is now recognized as a multisystem disorder that can persist for months after acute SARS-CoV-2 infection and frequently involves the cardiovascular and nervous systems. This paper aims to review the long-term cardiovascular and neurological manifestations of post-acute COVID-19, summarize the proposed mechanisms, organize major clinical observations, and discuss the implications for diagnosis, follow-up, and future research. Materials and Methods: A narrative review design was adopted using peer-reviewed reviews, large cohort studies, and authoritative public health sources published between 2021 and 2025. Sources were selected to represent three complementary domains: definitions and epidemiology of post-COVID condition, long-term cardiovascular outcomes, and long-term neurological outcomes. Emphasis was placed on studies with large sample sizes, 12-month follow-up, or clinically relevant synthesis of mechanisms such as endothelial dysfunction, immune dysregulation, microvascular injury, persistent inflammation, and autonomic imbalance. Evidence was then grouped into cardiovascular manifestations, neurological manifestations, pathophysiology, risk stratification, and management implications to produce a clinically structured review suitable for academic use.
Result
The reviewed literature shows that post-acute COVID-19 is associated with sustained cardiovascular risk extending beyond the first 30 days after infection, including increased risks of dysrhythmias, myocarditis, pericarditis, ischemic heart disease, thromboembolic disease, heart failure, and cerebrovascular disorders. Neurologically, post-COVID patients demonstrate a broad range of long-term sequelae including cognitive dysfunction, memory impairment, headache, sleep disturbance, anosmia, dysautonomia, neuropathy, stroke, seizures, encephalopathy, movement disorders, mood disorders, and Guillain-Barre syndrome.
Conclusion
Long-term cardiovascular and neurological manifestations of post-acute COVID-19 represent a clinically significant and durable consequence of SARS-CoV-2 infection that extends far beyond the respiratory phase of the disease. Recognition of these sequelae is essential because risk is not confined to previously critically ill patients; it is also present after mild or non-hospitalized infection. A multidisciplinary approach that integrates cardiovascular assessment, neurological evaluation, rehabilitation, symptom-guided investigation, and long-term surveillance is therefore warranted, while future research should focus on phenotype-specific biomarkers, prevention strategies, and therapeutic trials.
Zitieren
APA
Johri, S., Ambhore, S., & Jain, R. (2026). Long-Term Cardiovascular or Neurological Manifestations of Post-Acute COVID-19. International Journal of Current Pharmaceutical Review and Research, 18(03). https://doi.org/10.25258/ijcpr.18.3.232
Vancouver
Johri S, Ambhore S, Jain R. Long-Term Cardiovascular or Neurological Manifestations of Post-Acute COVID-19. International Journal of Current Pharmaceutical Review and Research. 2026;18(03). doi:10.25258/ijcpr.18.3.232
BibTeX
@article{Johri2026,
author = {Johri, Sanjeev and Ambhore, Sanjay and Jain, Rohit},
title = {Long-Term Cardiovascular or Neurological Manifestations of Post-Acute COVID-19},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {03},
doi = {10.25258/ijcpr.18.3.232}
}
EUVIMED